CSPIA
REGN icon

Cary Street Partners Investment Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$429K Sell
688
-43
-6% -$29.3K 0.09% 226
2026
Q1 		$565K Buy
731
+6
+0.8% +$4.59K 0.14% 156
2025
Q4 		$560K Buy
725
+331
+84% +$225K 0.15% 149
2025
Q3 		$222K Buy
394
+45
+13% +$25.4K 0.09% 244
2025
Q2 		$183K Sell
349
-23
-6% -$12.8K 0.09% 261
2025
Q1 		$236K Buy
372
+6
+2% +$4.13K 0.14% 181
2024
Q4 		$261K Sell
366
-3,708
-91% -$3.11M 0.17% 136
2024
Q3 		$4.28M Sell
4,074
-12
-0.3% -$13.4K 0.16% 150
2024
Q2 		$4.29M Buy
4,086
+696
+21% +$675K 0.17% 139
2024
Q1 		$3.26M Buy
3,390
+302
+10% +$287K 0.14% 171
2023
Q4 		$2.71M Buy
3,088
+427
+16% +$352K 0.13% 186
2023
Q3 		$2.19M Buy
2,661
+450
+20% +$354K 0.12% 202
2023
Q2 		$1.59M Buy
2,211
+1,959
+777% +$1.51M 0.1% 203
2023
Q1 		$207K Buy
252
+140
+125% +$106K 0.01% 462
2022
Q4 		$80.8K Buy
+112
New +$82.6K 0.01% 635
2022
Q3 		– Sell
-192
Closed -$113K – 552
2022
Q2 		$113K Buy
+192
New +$125K 0.01% 493
2020
Q4 		– Sell
-66
Closed -$37K – 741
2020
Q3 		$37K Buy
+66
New +$40K 0.01% 537

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Cary Street Partners Investment Advisory's REGN Position: Q2 2026 in Review

Cary Street Partners Investment Advisory reduced its Regeneron Pharmaceuticals (REGN) stake by 5.9% in Q2 2026, selling an estimated $29.3K and leaving 688 shares worth $429K. The position accounts for 0.09% of the portfolio, ranked #226.

Cary Street Partners Investment Advisory first reported a position in REGN in Q3 2020 and has held it in 17 quarters since. The position peaked at $4.29M in Q2 2024. 884 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Cary Street Partners Investment Advisory held 688 shares of Regeneron Pharmaceuticals worth $429K as of Q2 2026.
  • Cary Street Partners Investment Advisory sold 43 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $29.3K.
  • Regeneron Pharmaceuticals made up 0.09% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #226 holding.
  • Cary Street Partners Investment Advisory first reported a position in Regeneron Pharmaceuticals in Q3 2020 and has held it in 17 quarters since.
  • Cary Street Partners Investment Advisory's Regeneron Pharmaceuticals position peaked at $4.29M in Q2 2024.
  • 884 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.